GlassScriptPhysician profile
Grace E Paik
NPI 1689970014
$2,323.16
in general payments reported to CMS, 2019-2025
13 companies · $971 in 2025
The $971 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $224 · 2022: $174 · 2023: $442 · 2024: $512 · 2025: $971.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,925.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $846.99 | 2021-2025 | Dovato, Rukobia, Cabenuva |
| Merck Sharp & Dohme LLC | $406.31 | 2023-2025 | Pifeltro, Delstrigo, Dificid |
| Gilead Sciences, INC. | $388.14 | 2021-2025 | Biktarvy |
| Janssen Products, LP | $198.99 | 2021-2022 | |
| Janssen Biotech, INC. | $157.72 | 2021-2023 | Symtuza |
| Abbvie INC. | $115.43 | 2023-2025 | |
| Indivior INC. | $55.10 | 2024-2025 | Sublocade |
| Emd Serono, INC. | $43.85 | 2025 | |
| Theratechnologies INC. | $34.39 | 2023-2025 | Trogarzo, Egrifta |
| Napo Pharmaceuticals INC | $24.45 | 2025 | Mytesi |
| Lilly USA, LLC | $18.75 | 2025 | Mounjaro |
| Novartis Pharmaceuticals Corporation | $18.43 | 2024 | |
| Glaxosmithkline, LLC. | $14.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Paik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.